美股市場個股詳情

NVRO Nevro

添加自選

11.400
+0.230+2.06%

收盤價 05/17 16:00 (美東)

11.600
+0.200+1.75%

盤後 17:19 (美東)

4.19億總市值-5000市盈率TTM

Nevro股票討論區

登錄發表評論

Moomoo AI

02/25 21:35

Nevro's low P/S ratio may be due to its poor revenue outlook. Shareholders accept this as they anticipate no future revenue surprises. These conditions could continue to limit the share price.

Benign Growth For Nevro Corp. (NYSE:NVRO) Underpins Its Share Price

Moomoo AI

01/09 01:41

Nevro's growth strategy, prioritizing expansion over steady profits, is viewed as risky, leading to a rapidly declining share price. Despite insider purchases, the company's overall performance has been disappointing, resulting in an annual loss of 8% for shareholders over five years.

Shareholders in Nevro (NYSE:NVRO) Have Lost 89%, as Stock Drops 10% This Past Week

Moomoo AI

2023/11/16 20:30

Insiders buying shares over the past year, including one at a price higher than current, signals positive views of the company's future. While no insider transactions happened in recent three months, activities over the year suggest firm belief in potential.

Nevro Insider Ups Holding By 59% During Year

Moomoo AI

2023/10/10 20:38

The disappointing performance of Nevro's stock may be due to low growth and profit rates. Despite insider purchases, market sentiment towards Nevro remains negative, possibly an overreaction.

Further Weakness as Nevro (NYSE:NVRO) Drops 9.3% This Week, Taking Three-year Losses to 88%

Moomoo AI

2023/10/10 20:30

Despite Nevro's stock price plummeting, insiders buying shares in the past year, the company's ascent looks doubtful without significant profits and revenue growth.

Further Weakness as Nevro (NYSE:NVRO) Drops 9.3% This Week, Taking Three-year Losses to 88%

Movers and Shakers

2022/10/10 20:55

專欄Today's Pre-Market Stock Movers: RIVN, EDU, TLRY, F and More

Gapping up
News:
• $PyroGenesis Canada(PYR.US)$ +5.9% (announces that the negotiation for the land-based system to destroy PFAS contract has been suspended and discontinued)
• $Immatics(IMTX.US)$ +3.1% (announces a clinical data update for the IMA203)
• $iPATH 標普500 VIX短期期貨ETN(VXX.US)$ +1.6% (rising with softness in futures)
• $Nevro(NVRO.US)$ +1.4% (comments on $聯合健康(UNH.US)$ medical coverage policy u...

Movers and Shakers

2022/10/05 20:42

專欄Today's Pre-Market Stock Movers: TSLA, F, KORE, AMLX and More

Gapping up
In reaction to earnings/guidance:
$RPM International(RPM.US)$ +2.4%
Other news:
$Radiant Logistics(RLGT.US)$ +6.8% (to restate FY21 earnings)
$Stellus Capital Investment(SCM.US)$ +3.3% (declares Q4 dividends of $0.34 per share)
$金海洋集團(GOGL.US)$ +2.5% (authorizes new $100 mln share repurchase program)
$iPATH 標普500 VIX短期期貨ETN(VXX.US)$ +1.5% (rising with pull back in stock futures)
$Pebblebrook Hotel Trust(PEB.US)$ +1.3% (se...

Analysts Notebook

2022/05/05 19:49

專欄Top upgrades and downgrades on 5/5

Upgrades
• $美國資本代理公司(AGNC.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $13 (from $13.50)
• $Esperion Therapeutics(ESPR.US)$ : JP Morgan Upgrades to Neutral From Underweight
• $飛塔信息(FTNT.US)$ : Mizuho Securities Upgrades to Buy from Neutral - PT $350 (from $340)
• $Horizon Technology Finance(HRZN.US)$ : Compass Point Upgrades to Neutral From Sell
• $Momentive Global(MNTV.US)$ : Craig-Hallum Upgrades to Buy from Hold - PT $...

Analysts Notebook

2022/04/06 19:01

專欄Top upgrades and downgrades on 4/6

Upgrades
• $Banc of California(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $庫倫佛寺銀行(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $美國固安捷(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...

efficentupup

2022/02/21 15:07

Bill Gates says Covid risks have 'dramatically reduced' but another pandemic is coming

Bill Gates said that the risks of severe disease from Covid-19 have "dramatically reduced" but another pandemic is all but certain.
Speaking at Germany's annual Munich Security Conference, Gates said that a potential new pandemic would likely stem from a different pathogen.
Advances in medical technology could cut vaccine production times to six months, Gates added. $輝瑞(PFE.US)$ $Moderna(MRNA.US)$ $雅培(ABT.US)$ $Nevro(NVRO.US)$

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度